Results
|
41.
|
|
|
42.
|
|
|
43.
|
|
|
44.
|
|
|
45.
|
|
|
46.
|
|
|
47.
|
|
|
48.
|
The biological half-life of radioactive phosphorus in the blood of patients with leukemia. III. Erythrocytes; with deviations of observations from predicted values. [electronic resource] by
- TIVEY, H
- OSGOOD, E E
- KLINK, E
- McKENZIE, M
- HUGHES, M E
- ORT, J
- GUSTAFSON, I
- FULLER, M
- KLOBUCHER, V
- STODDARD, H
Producer: 20040215
In:
Cancer vol. 3
Availability: No items available.
|
|
49.
|
The biological half-life of radioactive phosphorus in the blood of patients with leukemia. II. Plasma; with deviations of observations from predicted values and an estimate of total-phosphorus turnover rate. [electronic resource] by
- OSGOOD, E E
- TIVEY, H
- KLINK, E
- McKENZIE, M
- HUGHES, M E
- ORT, J
- GUSTAFSON, I
- FULLER, M
- KLOBUCHER, V
- STODDARD, H
Producer: 20040215
In:
Cancer vol. 3
Availability: No items available.
|
|
50.
|
The biological half-life of radioactive phosphorus in the blood of patients with leukemia. I. Whole blood, with deviations of observations from predicted values and an estimate of total-phosphorus turnover rate. [electronic resource] by
- TIVEY, H
- OSGOOD, E E
- KLINK, E
- McKENZIE, M
- HUGHES, M E
- ORT, J
- GUSTAFSON, I
- FULLER, M
- KLOBUCHER, V
- STODDARD, H
Producer: 20040215
In:
Cancer vol. 3
Availability: No items available.
|
|
51.
|
The biological half-life of radioactive phosphorus in the blood of patients with leukemia. IV. Leukocytes; radioactive phosphorus content and the relation to plasma-P32 levels. [electronic resource] by
- OSGOOD, E E
- TIVEY, H
- KLINK, E
- McKENZIE, M
- HUGHES, M E
- ORT, J
- GUSTAFSON, I
- FULLER, M
- KLOBUCHER, V
- STODDARD, H
Producer: 20040215
In:
Cancer vol. 3
Availability: No items available.
|
|
52.
|
|
|
53.
|
The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers. [electronic resource] by
- Brewster, A M
- Etzel, C
- Zhou, R
- Wong, Y
- Edge, S
- Blayney, D W
- Wilson, J
- Hudis, C
- Ottesen, R
- Hughes, M E
- Weeks, J C
- Theriault, R L
Producer: 20120322
In:
Breast cancer research and treatment vol. 130
Availability: No items available.
|
|
54.
|
Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer. [electronic resource] by
- Waks, A G
- Cohen, O
- Kochupurakkal, B
- Kim, D
- Dunn, C E
- Buendia Buendia, J
- Wander, S
- Helvie, K
- Lloyd, M R
- Marini, L
- Hughes, M E
- Freeman, S S
- Ivy, S P
- Geradts, J
- Isakoff, S
- LoRusso, P
- Adalsteinsson, V A
- Tolaney, S M
- Matulonis, U
- Krop, I E
- D'Andrea, A D
- Winer, E P
- Lin, N U
- Shapiro, G I
- Wagle, N
Producer: 20210106
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 31
Availability: No items available.
|